Overview
- Gives insight into a new era of social psychopharmacology based on endogenous neuromodulators
- Discusses early-life treatment of social-cognitive deficiencies
- Provides cutting-edge information on "precision medicine"
Part of the book series: Current Topics in Behavioral Neurosciences (CTBN, volume 35)
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (26 chapters)
-
Front Matter
-
Animal Research Section
-
Front Matter
-
Keywords
About this book
This volume collects cutting-edge expert reviews in the oxytocin field and will be of interest to a broad scientific audience ranging from social neuroscience to clinical psychiatry. The role of the neuropeptide oxytocin in social behaviors is one of the earliest and most significant discoveries in social neuroscience. Influential studies in animal models have delineated many of the neural circuits and genetic components that underlie these behaviors. These discoveries have inspired researchers to investigate the effects of oxytocin on brain and behavior in humans and its potential relevance as a treatment for psychiatric disorders including borderline personality disorder and autism and schizophrenia spectrum disorders. In fact, there is no established social psychopharmacology in Psychiatry, and oxytocin can be seen as the first endogenous agent specifically addressing social-cognitive impairment in psychiatric disorders, with animal research suggesting that it could be especiallyefficient in the early postnatal period. From a human perspective, it is crucial to understand more precisely who can benefit from potential oxytocin-related treatments, which outcome measures will best represent their effects, how they should be administered, and what brain mechanisms are likely involved in mediating their effects. This type of “precision medicine” approach is in line with the research domain criteria defined by the U.S. National Institute of Mental Health.
Editors and Affiliations
Bibliographic Information
Book Title: Behavioral Pharmacology of Neuropeptides: Oxytocin
Editors: Rene Hurlemann, Valery Grinevich
Series Title: Current Topics in Behavioral Neurosciences
DOI: https://doi.org/10.1007/978-3-319-63739-6
Publisher: Springer Cham
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: Springer International Publishing AG, part of Springer Nature 2018
Hardcover ISBN: 978-3-319-63738-9Published: 14 July 2018
Softcover ISBN: 978-3-030-09703-5Published: 16 December 2018
eBook ISBN: 978-3-319-63739-6Published: 09 July 2018
Series ISSN: 1866-3370
Series E-ISSN: 1866-3389
Edition Number: 1
Number of Pages: IX, 593
Number of Illustrations: 63 b/w illustrations, 37 illustrations in colour
Topics: Neurosciences, Psychiatry, Behavioral Sciences, Endocrinology